HeidiUmphreyMD
Radiology • Germantown, TNAssistant Professor, Radiology, University of Alabama School of Medicine
Dr. Umphrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7600 Wolf River Blvd
Ste 200
Germantown, TN 38138Phone+1 901-747-1000Fax+1 901-747-1001
Education & Training
University of Alabama Medical CenterResidency, Radiology-Diagnostic, 2005 - 2009- University of Alabama Medical CenterFellowship, Neuropathology, 2004 - 2005
- University of Alabama Medical CenterResidency, Pathology-Anatomic and Clinical, 2002 - 2004
- University of Alabama HospitalInternship, Transitional Year, 2001 - 2002
University of Alabama School of MedicineClass of 2001
Certifications & Licensure
AL State Medical License 2003 - 2025
AR State Medical License 2017 - 2025
MS State Medical License 2017 - 2025
TN State Medical License 2017 - 2025
American Board of Pathology Anatomic Pathology
American Board of Radiology Diagnostic Radiology
Clinical Trials
- DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy Start of enrollment: 2012 Aug 27
- Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy Start of enrollment: 2015 Jun 01
Publications & Presentations
PubMed
- 18 citationsBreast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.Natsuko Onishi, Wen Li, David C. Newitt, Roy Harnish, Fredrik Strand
Radiology. 2021-08-24 - 14 citationsA Randomized Phase IIb Study of Low-dose Tamoxifen in Chest-irradiated Cancer Survivors at Risk for Breast CancerSmita Bhatia, Melanie R. Palomares, Lindsey Hageman, Yanjun Chen, Wendy Landier
Clinical Cancer Research. 2021-02-15 - 35 citationsPredicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL.Wen Li, David C. Newitt, Jessica Gibbs, Lisa J. Wilmes, Ella F. Jones
NPJ Breast Cancer. 2020-11-27
Press Mentions
- Predicting Breast Cancer Response to Neoadjuvant Treatment Using Multi-Feature MRI: Results from the I-SPY 2 TRIALNovember 27th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
